BEAM
Price
$23.30
Change
-$2.24 (-8.77%)
Updated
Jan 14 closing price
Capitalization
1.93B
48 days until earnings call
IONS
Price
$32.68
Change
-$2.26 (-6.47%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
5.16B
35 days until earnings call
Ad is loading...

BEAM vs IONS

Header iconBEAM vs IONS Comparison
Open Charts BEAM vs IONSBanner chart's image
Beam Therapeutics
Price$23.30
Change-$2.24 (-8.77%)
Volume$2.4M
Capitalization1.93B
Ionis Pharmaceuticals
Price$32.68
Change-$2.26 (-6.47%)
Volume$34.43K
Capitalization5.16B
BEAM vs IONS Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. IONS commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and IONS is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (BEAM: $23.30 vs. IONS: $32.69)
Brand notoriety: BEAM and IONS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 198% vs. IONS: 131%
Market capitalization -- BEAM: $1.93B vs. IONS: $5.16B
BEAM [@Biotechnology] is valued at $1.93B. IONS’s [@Biotechnology] market capitalization is $5.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileIONS’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • IONS’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than IONS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while IONS’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 3 bearish.
  • IONS’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than IONS.

Price Growth

BEAM (@Biotechnology) experienced а -13.96% price change this week, while IONS (@Biotechnology) price change was -6.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

IONS is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IONS($5.16B) has a higher market cap than BEAM($1.93B). BEAM YTD gains are higher at: -6.048 vs. IONS (-6.493). BEAM has higher annual earnings (EBITDA): -160.83M vs. IONS (-249.52M). IONS has more cash in the bank: 2.48B vs. BEAM (926M). BEAM has less debt than IONS: BEAM (162M) vs IONS (1.45B). IONS has higher revenues than BEAM: IONS (803M) vs BEAM (350M).
BEAMIONSBEAM / IONS
Capitalization1.93B5.16B37%
EBITDA-160.83M-249.52M64%
Gain YTD-6.048-6.49393%
P/E RatioN/AN/A-
Revenue350M803M44%
Total Cash926M2.48B37%
Total Debt162M1.45B11%
FUNDAMENTALS RATINGS
IONS: Fundamental Ratings
IONS
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
68
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMIONS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
66%
Momentum
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
72%
MACD
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 7 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
83%
Bearish Trend 7 days ago
70%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 22 days ago
61%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 16 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
74%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 7 days ago
72%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FEZ48.960.46
+0.95%
SPDR® EURO STOXX 50 ETF
LVHD38.110.30
+0.79%
Franklin U.S. Low Volatility Hi Div ETF
GREK39.700.25
+0.63%
Global X MSCI Greece ETF
TYD22.480.02
+0.09%
Direxion Daily 7-10 Yr Trs Bull 3X ETF
TINY45.24N/A
N/A
ProShares Nanotechnology ETF